This report provides supplementary data to Chapter 4 of AURA 2023: Fifth Australian report on antimicrobial use and resistance in human health.
On the Radar Issue 627 is now available.
On the Radar Issue 628 is now available.
Register for our webcast to hear leading experts discuss how the Standards will improve care in Australia and what these changes mean for the industry.
Register for our webcast to hear leading experts discuss how the Standards will improve care in Australia and what these changes mean for the industry.
MEDIA RELEASE
Australians are unwittingly being exposed to increased risk of harm from taking antibiotics, when often these medicines are used to treat common infections where they will have no or little benefit.
AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health is being released on 16 November 2023, highlighting data trends and analyses across acute and community care settings.
This Key Findings summary features the most compelling data findings from AURA 2023, with excerpts taken from the report for easy reference.
Australians are unwittingly being exposed to increased risk of harm from taking antibiotics, when often these medicines are used to treat common infections where they will have no or little benefit, according to the Australian Commission on Safety and Quality in Health Care.
Released 16 November 2023
This resource outlines what antimicrobial resistance (AMR) is, and how we need to limit our use of antimicrobials – such as antibiotics, antivirals, antifungals and antiparasitics – to reduce the risk of drug-resistant infections and impact of AMR.
AURA 2023: Fifth Australian Report on Antimicrobial Use and Resistance in Human Health was released on 16 November 2023, highlighting data trends and analyses across acute and community care settings.
This A4 infographic showcases key data highlights from AURA 2023 on antimicrobial use in Australia.